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 Abstract: 
 
Mutations of the transcripton factor 4 (TCF4) gene cause mental 
retardation with or without associated facial dysmorphisms and 
intermittent hyperventilation. Subsequently, a polymorphism of TCF4 
was shown in a genome-wide association study to slightly increase the 
risk for schizophrenia. We have further analysed the impact of this TCF4 
variant rs9960767 on early information processing and cognitive 
functions in schizophrenia patients. We have shown in a sample of 401 
schizophrenia patients that TCF4 influences verbal memory in the Rey 
Auditory Verbal Learning Test. Contrary to expectations, carriers of the 
schizophrenia-associated allele showed better recognition, thus 
indicating that while TCF4 influences verbal memory, the TCF4-mediated 
schizophrenia risk is not determined by the influence of TCF4 on verbal 
memory. TCF4 does not impact on various other cognitive functions 
belonging to the domains of attention and executive functions. Moreover, 
in a pharmacogenetic approach, TCF4 does not modulate the 
improvement of positive or negative schizophrenia symptoms during 
treatment with antipsychotics. Finally, we have assessed a key 
electrophysiological endophenotype of schizophrenia, sensorimotor 
gating. As measured by prepulse inhibition, the schizophrenia risk allele 
C of TCF4 rs9960767 reduces sensorimotor gating. This indicates that 
TCF4 influences key mechanisms of information processing which may 
contribute to the pathogenesis of schizophrenia.  
 Introduction 
 
The elucidation of the genetic causes of schizophrenia is progressing 
rapidly. In the present review, we want to focus on the gene named 
transcription factor 4 (TCF4). In 2007, disruption of the TCF4 gene was 
shown to cause Pitt-Hopkins syndrome [1, 4, 40]. Pitt-Hopkins syndrome 
was described in 1978 as a syndrome of mental retardation, 
microcephaly, facial dysmorphisms, and intermittent hyperventilation 
[25]. Seizures also frequently occur in the syndrome [33]. In 2008, it was 
shown that a mutation of TCF4 may also cause mental retardation 
without the associated features of Pitt-Hopkins syndrome, i.e. without 
hyperventilation or seizures [18]. This established TCF4 as a cause of 
non-syndromal mental retardation. In the following year, a large genome-
wide association study showed that a common intronic variant of TCF4 
(rs9960767) leads to a slight increase in the risk of schizophrenia, with a 
relative risk of 1.23 [35]. Here, we discuss further findings on cognitive 
and electrophysiological endophenotypes of schizophrenia to further 
explore the mechanisms how TCF4 is involved in the development of 
schizophrenia.  
 
 
TCF4 and cognitive endophenotypes of schizophrenia 
 
 
A role of the TCF4 gene in neuropsychological functioning can be 
assumed following different findings: First, TCF4 may be essential for 
normal brain development as has been demonstrated in a study 
conducted by Flora et al. [13]. In this study, an interaction of TCF4 and 
MATH1, a proneural protein, on different neural progenitor populations 
was investigated and disrupted pontine nucleus development was found 
in TCF4 knock out mice. Second, several studies showed that TCF4 
haploinsufficiency contributes to severe neurodevelopmental disorders 
such as the Pitt-Hopkins syndrome [1, 4, 9, 33, 40]. This autosomal 
dominant encephalopathy is characterized by severe mental retardation, 
microcephaly, disrupted motor development, and hyperventilation, as 
described above [25]. Third, animal studies showed that TCF4 knock-out 
mice die within 24 hours after birth [13]. However, a recent animal study 
investigated transgenic mice mildly overexpressing TCF4 in the brain 
postnatally which allowed studying their behavioural phenotype [5]. As 
compared to their wildtype littermates, the TCF4 transgenic mice showed 
less freezing in a fear conditioning paradigm suggesting deficient fear-
related learning and memory. Moreover, the mutant mice in this study 
also showed disrupted PPI (see below). Together these findings in 
humans and animals argue for a potential role of TCF4 in 
neurofunctional disruptions ranging from non-viable (as seen in animal 
TCF4 null mutants) to severe mental retardation (as seen in Pitt Hopkins 
syndrome caused by TCF4 haploinsufficiency) to mild cognitive 
impairments (as seen in a girl carrying a de novo translocation with 
disruption of TCF4 presenting with mild mental retardation) [18]. 
Partly based on these findings, we sought to examine the role of the 
common TCF4 schizophrenia risk variant rs9960767 on verbal memory 
in a sample of schizophrenia patients [21]. Impaired verbal memory is 
among the most prominent cognitive deficits of schizophrenia [10]. 
Moreover, studies examining unaffected relatives from multiple affected 
families (“multiplex families”) and twin studies emphasize the role of 
verbal memory as a promising endophenotype of schizophrenia. These 
highly informative study designs reliably demonstrate an increasing 
memory deficit along with the increasing genetic load [8, 11, 38]. 
In our study [21], we investigated a sample of 401 schizophrenia 
patients, all of whom were genotyped for the rs9960767 variant and 
completed a neuropsychological verbal memory test. Verbal memory 
was assessed using the Rey Auditory Verbal Memory Test (RAVLT, 
[17]). In addition, verbal intelligence as well as age, gender, age at onset, 
duration of illness, medication type (typical vs. atypical neuroleptics), and 
DSM-IV schizophrenia subtype were also analysed as control variables. 
Comparing schizophrenia patients carrying the TCF4 C-Allele (risk allele) 
against patients with an AA genotype yielded no significant effects for 
any of the control variables including verbal intelligence (all p > .20). No 
effect of the C-allele on immediate recall and total learning was found. A 
trend finding for delayed verbal memory emerged, which however 
indicated better performance in carriers of the risk variant compared to 
non-carriers. With regard to recognition, schizophrenia patients carrying 
at least one C-allele significantly recognized more words compared to 
patients without the risk variant. We also explored functional effects of 
the TCF4 variant rs9960767 on a comprehensive neuropsychological 
test battery in a subsample of nearly 200 schizophrenia patients and an 
additional sample of 205 healthy volunteers (unpublished data). No 
differences between TCF4 C-allele carriers or subjects with AA-genotype 
were found with regard to age, gender, and verbal intelligence in both 
groups. The assessed cognitive functions attention and vigilance, 
working memory, processing speed, visuo-motor speed and set-shifting, 
and verbal fluency were all unaffected by rs9960767 in both groups 
(unpublished data). Of note, although TCF4 mutations are clearly related 
to severely disrupted intellectual functions, no effect of the rs9960767 
polymorphism on verbal intelligence or any other neuropsychological 
function was evident in our sample [21]. 
Thus, different arguments emphasize a role of TCF4 in 
neuropsychological functions. While mutations of this gene lead to 
severe cognitive deficits, also milder cognitive alterations due to common 
variants within the TCF4 gene or due to changes at the transcript level 
were observed. Our study showed that the common TCF4 variant 
rs9960767 exerts an effect on recognition memory. Brzózka et al. 
investigated mice mildly over-expressing TCF4 and found reduced fear-
related memory and difficulties to unlearn a previously rewarded spatial 
locus [5]. Both studies differ with regard to investigated subjects (mice 
versus schizophrenia patients), materials (fear conditioning and spatial 
memory versus verbal declarative memory), and assessed genetic 
variability (transgenic mice versus single nucleotide polymorphism) 
which makes them difficult to relate to each other. However, both studies 
suggest a role of TCF4 in memory functions. Thus they support the 
notion that not only TCF4 mutations but also more subtle genetic 
variation affects neuropsychological functions.  
 
 
TCF4 and sensorimotor gating 
 
Prepulse inhibition (PPI) of the acoustic startle response (ASR) has been 
firmly established as an operational measure of sensorimotor gating [3]. 
PPI is defined as a strong reduction of the amplitude of the startle 
response that occurs when a distinctive non-startling stimulus is 
presented 30-500 ms prior to the startling stimulus [15]. It was proposed 
that the mechanism underlying PPI regulates sensory input by filtering 
out irrelevant or distracting stimuli in order to prevent sensory information 
overflow and to allow for selective and efficient processing of relevant 
information [36]. Given that PPI was shown for visual, electric, and 
auditory stimuli (also for a cross modal combination of different stimuli 
types) and that PPI is measurable in several species ranging from 
mollusks and fish to higher mammals such as rodents, non-human 
primates, and humans, it is thought to reflect a fundamental mechanism 
of preattentional information processing (for review see [26]). 
Diminished PPI has been consistently demonstrated in patients with 
schizophrenia [3, 20, 22, 23, 32] and schizotypal personality disorder [6, 
7]. The PPI deficit in schizophrenia is supposed to reflect a central 
abnormality underlying the disease; both neuroanatomical and 
neurochemical factors have been implicated on the basis of animal 
studies, which suggest contributions of diverse neurotransmitter 
systems, and particular functional association with multiple loci in the 
cortico-striato-pallido-thalamic (CSPT) circuitry, frontal and 
mediotemporal regions, ventral striatum, ventral pallidum, and pontine 
regions of the brainstem [12, 37]. Furthermore, PPI is heritable [2, 16], 
decreased in unaffected relatives of schizophrenia patients [7, 19], 
affected by SNPs within the dopamine, acetylcholine, and serotonin 
system [24, 29-31, 34] and already reduced during the prodromal stage 
of schizophrenia [28, 39], suggesting that PPI is an important and valid 
candidate as an intermediate or endophenotypic marker in genetic 
studies of schizophrenia [14]. 
In two independent samples, we recently demonstrated that the 
schizophrenia risk allele C of the TCF4 rs9960767 SNP is strongly 
associated with reduced sensorimotor gating [27]. In accordance with 
recent animal data, showing that transgenic mice overexpressing the 
TCF4 gene in the brain display decreased sensorimotor gating [5], this 
finding suggests that TCF4 plays an important role in the development of 
early information deficits in schizophrenia at least in a subgroup of 
patients who display diminished PPI. It was recently shown in TCF4 
knock-out mice that TCF4 plays a unique role especially in the 
development of the pontine nuclei [13], which are highly connected with 
other brain stem nuclei that are critical core regions within the CSPP 
circuitry processing PPI of ASR [12, 37]. Although the influence of 
pontine nuclei on PPI has not been directly studied so far, one might 
assume that developmental changes in these regions caused by TCF4 
mutations are possibly associated with functional alterations of 
interconnections to adjacent brain stem nuclei as well as of the cortico-
ponto-cerebellar integration of sensorimotor information. This 
assumption is also supported by the fact that PPI was strongly affected 
by TCF4 genotype across the entire range of SOA conditions – from the 
“preconscious” 30 ms SOA to the “conscious” 120 SOA. This pattern 
suggests that TCF4 genotype probably influences PPI at an early level of 
information processing. Finally, given that TCF4 genotype was 
significantly associated with PPI reduction, a combination of TCF4 
genotype and a PPI deficit syndrome might be a promising marker for 
the early detection of schizophrenia [27]. 
 
 
 
 
 
Pharmacogenetics of TCF4 
 
To assess whether TCF4 influences the antipsychotic drug response in 
schizophrenia, we have analysed the TCF4 polymorphism rs9960767 in 
two independent samples of schizophrenia patients comprising more 
than 200 patients in total. The schizophrenia patients were admitted to 
hospital due to an exacerbation of psychotic symptoms. TCF4 rs9960767 
was genotyped as described previously [21]. We assessed the 
improvement of the PANSS scale and subscales during neuroleptic 
treatment over four weeks. We did not find a significant influence of 
TCF4 rs9960767 on the improvement of positive symptoms, negative 
symptoms, general psychopathology, or total PANSS score. Bonferroni 
correction was employed to control for multiple testing. The findings 
argue against an important pharmacogenetic role of TCF4 in the 
antipsychotic drug response of schizophrenia patients. 
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